APH vs DTIL · P/E 40, rev $16.38B vs rev $10.8M
Amphenol Corporation (APH) versus Precision BioSciences Inc (DTIL) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Precision BioSciences Inc (DTIL) is a biotechnology company listed on US.
Latest reported APH revenue for 2026-06-30 was $16.38B. Net income was $2.70B. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported DTIL revenue for 2026-06-30 was $10.8M. Net income was -$51.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. DTIL currently screens at market cap $48.1M.
APH currently screens at market cap $170.77B and trailing P/E 39.9. DTIL currently screens at market cap $48.1M.
Not investment advice. Open the APH and DTIL stock pages for the full models.
Not investment advice.